Heart Valves - Biological: Market Size & Forecast 2026

The global biological heart valve market reached approximately USD 5.8 billion in 2025 as the base year, anchored by surgical tissue valve replacement procedures that remain the standard of care for patients over 65. An 8.2% CAGR projects the category to roughly USD 10 billion by 2032, driven by demographic tailwinds in OECD nations, continued surgeon preference for bioprosthetic over mechanical valves in the over-65 cohort, and an emerging transcatheter biological valve ecosystem that is reshaping the competitive map. Tissue sourcing costs, bovine pericardium and porcine valve tissue, account for 28% of finished unit cost, making feedstock availability and anti-calcification treatment chemistry the two structural cost inflection points buyers must manage in any multi-year supply agreement. > Synthesised from secondary and publicly verifiable sources via Claight Category Watch:

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.